Bulk Manufacturer of Controlled Substances Application: Organix Inc., 72274-72275 [2021-27635]
Download as PDF
<![CDATA[
72274
Federal Register / Vol. 86, No. 242 / Tuesday, December 21, 2021 / Notices
requested by the complainant in this
investigation would affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles potentially
subject to the requested remedial orders are
used in the United States;
(ii) identify any public health, safety, or
welfare concerns in the United States relating
to the requested remedial orders;
(iii) identify like or directly competitive
articles that complainant, its licensees, or
third parties make in the United States which
could replace the subject articles if they were
to be excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third party
suppliers have the capacity to replace the
volume of articles potentially subject to the
requested exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested remedial
orders would impact United States
consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due. No other submissions will be
accepted, unless requested by the
Commission. Any submissions and
replies filed in response to this Notice
are limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. Submissions should refer
to the docket number (‘‘Docket No.
3582’’) in a prominent place on the
cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, Electronic Filing
Procedures 1). Please note the
Secretary’s Office will accept only
electronic filings during this time.
Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov.) No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary at EDIS3Help@usitc.gov.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: December 15, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–27547 Filed 12–20–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–940]
Bulk Manufacturer of Controlled
Substances Application: Organix Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Organix Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 22, 2022. Such
persons may also file a written request
for a hearing on the application on or
before February 22, 2022.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 16, 2021,
Organix Inc., 240 Salem Street, Woburn,
Massachusetts 01801–2029, applied to
be registered as a bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
jspears on DSK121TN23PROD with NOTICES1
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
3,4,5- Trimethoxyamphetamine .......................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
VerDate Sep<11>2014
18:02 Dec 20, 2021
Jkt 256001
2 All contract personnel will sign appropriate
nondisclosure agreements.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
2010
7315
7360
7370
7381
7390
7392
7400
Schedule
I
I
I
I
I
I
I
I
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
E:\FR\FM\21DEN1.SGM
21DEN1
72275
Federal Register / Vol. 86, No. 242 / Tuesday, December 21, 2021 / Notices
Controlled substance
Drug code
3,4-Methylenedioxymethamphetamine ............................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Alpha-Methyltryptamine ...................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .................................................................................................................
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) .......................................................................................................
Heroin ..............................................................................................................................................................................
Morphine ..........................................................................................................................................................................
The company plans to synthesize the
above listed controlled substances for
distribution to its customers. In
reference to dug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
CONTACT PERSON FOR MORE INFORMATION:
Requests for information, advance
notices of intention to observe an open
meeting, and requests for teleconference
dial-in information may be directed to:
Patricia M. Hall, Foreign Claims
Settlement Commission, 441 G St. NW,
Room 6234, Washington, DC 20579.
Telephone: (202) 616–6975.
Jeremy R. LaFrancois,
Chief Administrative Counsel.
[FR Doc. 2021–27760 Filed 12–17–21; 2:00 pm]
[FR Doc. 2021–27635 Filed 12–20–21; 8:45 am]
BILLING CODE 4410–BA–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Foreign Claims Settlement
Commission
[F.C.S.C. Meeting and Hearing Notice No.
01–22]
jspears on DSK121TN23PROD with NOTICES1
Sunshine Act Meeting
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR part 503.25) and the
Government in the Sunshine Act (5
U.S.C. 552b), hereby gives notice in
regard to the scheduling of open
meetings as follows:
TIME AND DATE: Thursday, January 13,
2022, at 10:00 a.m. EST.
PLACE: This meeting will be held by
teleconference. There will be no
physical meeting place.
STATUS: Open. Members of the public
who wish to observe the meeting via
teleconference should contact Patricia
M. Hall, Foreign Claims Settlement
Commission, Tele: (202) 616–6975, two
business days in advance of the
meeting. Individuals will be given callin information upon notice of
attendance to the Commission.
MATTERS TO BE CONSIDERED: 10:00 a.m.—
Issuance of Proposed Decisions under
the Guam World War II Loyalty
Recognition Act, Title XVII, Public Law
114–328.
VerDate Sep<11>2014
18:02 Dec 20, 2021
Jkt 256001
7405
7431
7432
7433
7434
7435
7437
7438
7508
7517
7518
9200
9300
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
II
comment on the proposed consent
decree for thirty (30) days from the date
of publication of this notice. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. City of
Woonsocket and Synagro Northeast,
LLC, D.J. Ref. No. 90–5–2–1–12275. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
DEPARTMENT OF JUSTICE
To submit
comments:
Send them to:
Notice of Lodging of Proposed
Consent Decree Under The Clean Air
Act
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
On December 13, 2021, the
Department of Justice lodged a proposed
consent decree with the United States
District Court for the District of Rhode
Island, in the lawsuit entitled United
States v. City of Woonsocket and
Synagro Northeast, LLC, Civil Action
No. 1:21–c–491.
The United States filed this lawsuit
under Sections 113(b) and 129(f) of the
Clean Air Act, 42 U.S.C. 7413(b), 7429(f)
and 40 CFR part 62, subpart LLL,
against the owner and operator of a
sewage sludge incinerator at a
municipal wastewater treatment facility
in Woonsocket, Rhode Island. The
complaint seeks civil penalties and
injunctive relief arising from alleged
violations of requirements to (1) submit
monthly status reports, a final control
plan, and a site-specific monitoring
plan; (2) perform required testing; (3)
meet emission limits for sulfur dioxide
and hydrochloric acid; and (4) establish
and meet operating limits. The consent
decree requires the settling defendants
to pay a civil penalty of $373,660, plus
interest, and to take measures to bring
the facility into compliance.
By this notice, the Department of
Justice opens a period of public
PO 00000
Frm 00073
Fmt 4703
Sfmt 9990
By mail .........
During the public comment period,
the consent decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
Paper copies of the consent decree are
available upon written request and
payment of reproduction costs. Such
requests and payments should be
addressed to:
Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington,
DC 20044–7611
With each such request, please
enclose a check or money order for
$10.75 (25 cents per page reproduction
cost) per paper copy, payable to the
United States Treasury.
Henry S. Friedman,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2021–27524 Filed 12–20–21; 8:45 am]
BILLING CODE 4410–15–P
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 86, Number 242 (Tuesday, December 21, 2021)]
[Notices]
[Pages 72274-72275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27635]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-940]
Bulk Manufacturer of Controlled Substances Application: Organix
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Organix Inc. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before February 22,
2022. Such persons may also file a written request for a hearing on the
application on or before February 22, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 16, 2021, Organix Inc., 240 Salem Street,
Woburn, Massachusetts 01801-2029, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......... 2010 I
Lysergic acid diethylamide......... 7315 I
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Mescaline.......................... 7381 I
3,4,5- Trimethoxyamphetamine....... 7390 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
3,4-Methylenedioxyamphetamine...... 7400 I
[[Page 72275]]
3,4-Methylenedioxymethamphetamine.. 7405 I
5-Methoxy-N-N-dimethyltryptamine... 7431 I
Alpha-Methyltryptamine............. 7432 I
Bufotenine......................... 7433 I
Diethyltryptamine.................. 7434 I
Dimethyltryptamine................. 7435 I
Psilocybin......................... 7437 I
Psilocyn........................... 7438 I
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxyphenyl) ethanamine 7517 I
(2C-H).
2-(4-Iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
Heroin............................. 9200 I
Morphine........................... 9300 II
------------------------------------------------------------------------
The company plans to synthesize the above listed controlled
substances for distribution to its customers. In reference to dug codes
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans
to bulk manufacture these drugs as synthetic. No other activities for
these drug codes are authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-27635 Filed 12-20-21; 8:45 am]
BILLING CODE 4410-09-P
